A Prospective Pharmacoeconomic Study of Bilateral Prostaglandin/ Prostamide Therapy for Lowering Intraocular Pressure (Iop) in the Patients in South India

To determine monthly cost and cost effectiveness of bilateral prostaglandin/ prostamide therapy for lowering intraocular pressure (IOP) in patients taking bimatoprost (0.03%), latanoprost (0.005%), or travoprost (0.004%).
Source: Value in Health - Category: Global & Universal Authors: Source Type: research